Antares Pharma Escapes Fraud Suit Over Drug Statements
A New Jersey federal judge on Tuesday nixed a proposed securities class action against Antares Pharma Inc. after finding that a shareholder failed to back up his claims that the company...To view the full article, register now.
Already a subscriber? Click here to view full article